Founders Capital Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 1 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Founders Capital Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$1,087
-54.7%
2,000
-50.0%
0.00%
-50.0%
Q3 2023$2,399
-53.9%
4,0000.0%0.00%
-50.0%
Q2 2023$5,200
+74185.7%
4,0000.0%0.00%
-20.0%
Q1 2023$7
+16.7%
4,000
+100.0%
0.01%0.0%
Q4 2022$6
-99.9%
2,000
+100.0%
0.01%
+25.0%
Q3 2022$5,000
+25.0%
1,0000.0%0.00%
+33.3%
Q2 2022$4,000
-50.0%
1,0000.0%0.00%
-40.0%
Q1 2022$8,0000.0%1,0000.0%0.01%0.0%
Q4 2021$8,000
-11.1%
1,0000.0%0.01%
-16.7%
Q3 2021$9,0001,0000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders